Why are immunizations particularly important for older adults?

Older adults experience immunosenescence, a decline in immune function with age, making them more susceptible to infectious diseases and increasing their risk of severe complications, hospitalization, and mortality from vaccine-preventable illnesses.

What is immunosenescence and how does it affect vaccine efficacy?

Immunosenescence is the gradual deterioration of the immune system with age. It can lead to a reduced ability to mount a robust immune response to vaccines, potentially necessitating higher antigen doses or adjuvanted formulations to achieve adequate protection.

Which influenza vaccine formulations are recommended for adults aged 65 years and older?

For adults aged 65 years and older, ACIP preferentially recommends higher-dose or adjuvanted influenza vaccines, such as the quadrivalent high-dose inactivated influenza vaccine (HD-IIV4) or the quadrivalent adjuvanted inactivated influenza vaccine (aIIV4), over standard-dose unadjuvanted vaccines.

What are the current pneumococcal vaccination recommendations for older adults?

As of April 2026, ACIP generally recommends a single dose of PCV20 for adults aged ≥65 years who have not previously received a pneumococcal conjugate vaccine, or a sequential regimen of PCV15 followed by PPSV23 for those who prefer that option. Shared clinical decision-making is key.

Who should receive the recombinant zoster vaccine (RZV) and what is the dosing schedule?

RZV (Shingrix) is recommended for all immunocompetent adults aged 50 years and older, regardless of prior zoster history or previous receipt of the live zoster vaccine. It is administered as a two-dose series, with the second dose given 2 to 6 months after the first.

What role do pharmacists play in improving immunization rates among older adults?

Pharmacists are crucial for improving immunization rates by identifying eligible patients, administering vaccines, educating patients and caregivers, addressing vaccine hesitancy, maintaining accurate immunization records, and collaborating with other healthcare providers.

What is 'shared clinical decision-making' in the context of adult immunizations?

Shared clinical decision-making involves a discussion between the patient and their healthcare provider about the risks and benefits of a particular vaccine, considering the patient's individual health status, preferences, and values, before making a vaccination decision. This applies to vaccines like RSV and certain pneumococcal options for older adults.

Immunizations for Older Adults: Essential Knowledge for the CGP Certified Geriatric Pharmacist Exam

Q: Are there specific RSV vaccines recommended for older adults?

Yes, as of April 2026, two RSV vaccines (Arexvy and Abrysvo) are recommended for adults aged 60 years and older based on shared clinical decision-making. These vaccines help protect against severe lower respiratory tract disease caused by RSV.

Immunizations for Older Adults: A Core Competency for CGP Certified Geriatric Pharmacists

As an aspiring CGP Certified Geriatric Pharmacist, mastering the nuances of immunizations for older adults is not just a regulatory requirement; it's a cornerstone of patient care. The geriatric population faces unique challenges when it comes to vaccine-preventable diseases, primarily due to age-related changes in the immune system, known as immunosenescence, and a higher prevalence of chronic medical conditions. This mini-article will delve into the critical aspects of immunizations in older adults, equipping you with the knowledge necessary to excel on the CGP exam and, more importantly, to optimize health outcomes for your geriatric patients.

The CGP exam consistently tests candidates on their understanding of appropriate vaccine schedules, contraindications, special considerations, and the pharmacist's integral role in promoting vaccine uptake among older adults. A robust grasp of this topic demonstrates your ability to apply evidence-based recommendations to complex patient scenarios, a hallmark of geriatric pharmacy practice.

Key Concepts in Geriatric Immunization

Understanding the fundamental principles behind immunization recommendations for older adults is paramount. These principles are rooted in the physiological changes of aging and the epidemiology of infectious diseases.

Immunosenescence and Its Impact

Immunosenescence refers to the age-related decline in immune system function. This decline manifests as:

Reduced production of naive T-cells and B-cells.
Decreased antibody response to new antigens.
Lower affinity of antibodies produced.
Impaired cell-mediated immunity.
Chronic low-grade inflammation (inflammaging).

These changes make older adults more susceptible to infections and can lead to a diminished response to standard vaccine formulations. Consequently, specific vaccine strategies, such as higher-dose or adjuvanted vaccines, are often recommended to overcome these age-related immune deficits.

Essential Vaccines for Older Adults (as of April 2026)

The Advisory Committee on Immunization Practices (ACIP) provides comprehensive guidelines that form the basis of vaccination recommendations in the United States. For older adults, several vaccines are particularly critical:

Influenza Vaccine

Annual influenza vaccination is universally recommended for all adults. For those aged 65 years and older, ACIP preferentially recommends higher-dose or adjuvanted inactivated influenza vaccines due to their superior immunogenicity and efficacy compared to standard-dose unadjuvanted vaccines. Options include:

Quadrivalent high-dose inactivated influenza vaccine (HD-IIV4)
Quadrivalent adjuvanted inactivated influenza vaccine (aIIV4)

These formulations are designed to elicit a stronger immune response in the aging immune system.

Pneumococcal Vaccines

Pneumococcal disease, caused by Streptococcus pneumoniae, can lead to severe pneumonia, meningitis, and bacteremia, with significantly higher morbidity and mortality in older adults. Current ACIP recommendations (as of April 2026) for adults aged 65 years and older who have not previously received a pneumococcal conjugate vaccine are:

A single dose of PCV20 (Pneumococcal Conjugate Vaccine 20-valent).
Alternatively, a sequential regimen of PCV15 (Pneumococcal Conjugate Vaccine 15-valent) followed by a dose of PPSV23 (Pneumococcal Polysaccharide Vaccine 23-valent) at least 1 year later (or 8 weeks if immunocompromised).

Shared clinical decision-making is important when choosing between these options, considering patient preferences and individual risk factors. Pharmacists must be adept at counseling patients through these choices and ensuring correct sequencing if a multi-dose regimen is selected.

Herpes Zoster Vaccine (Shingles)

Herpes zoster (shingles) is caused by the reactivation of the varicella-zoster virus and is more common and severe in older adults. The recombinant zoster vaccine (RZV, Shingrix) is highly effective and recommended for all immunocompetent adults aged 50 years and older.

Dosing: Two doses administered intramuscularly, 2 to 6 months apart.
Considerations: Recommended regardless of prior zoster history or previous receipt of the older live attenuated zoster vaccine (Zostavax), which is no longer preferentially recommended.

Tetanus, Diphtheria, and Pertussis (Tdap/Td)

Adults need a tetanus and diphtheria (Td) booster every 10 years. A single dose of Tdap (tetanus, diphtheria, acellular pertussis) is recommended for all adults who have not previously received it, especially if they have close contact with infants or are healthcare personnel. After the initial Tdap dose, Td boosters are given every 10 years.

Respiratory Syncytial Virus (RSV) Vaccines

RSV can cause severe lower respiratory tract disease in older adults, leading to hospitalizations and deaths. As of April 2026, two RSV vaccines are available and recommended for adults aged 60 years and older based on shared clinical decision-making:

Arexvy (GSK)
Abrysvo (Pfizer)

Pharmacists play a key role in discussing the benefits and risks with eligible patients to facilitate informed decisions.

COVID-19 Vaccines

Recommendations for COVID-19 vaccines continue to evolve. For older adults, staying up-to-date with the latest recommended primary series and booster doses is crucial due to their increased risk of severe disease and complications. Pharmacists should consult current CDC/ACIP guidance for the most recent recommendations regarding formulations and schedules.

The Pharmacist's Role in Immunization

Pharmacists are frontline healthcare providers ideally positioned to improve immunization rates among older adults. Their responsibilities include:

Screening: Identifying patients eligible for vaccines based on age, medical history, and current recommendations.
Administration: Safely and competently administering vaccines.
Education and Counseling: Providing clear, accurate information about vaccine benefits, risks, potential side effects, and addressing vaccine hesitancy.
Record-Keeping: Documenting vaccinations accurately in state immunization registries and patient records.
Collaboration: Working with physicians and other healthcare providers to ensure comprehensive care.
Advocacy: Promoting public health initiatives and advocating for policies that expand vaccine access.

How Immunizations for Older Adults Appears on the CGP Exam

The CGP Certified Geriatric Pharmacist practice questions frequently feature scenarios requiring you to apply your knowledge of immunizations. Expect questions that:

Present patient cases: You'll be given a patient's age, medical history (e.g., chronic obstructive pulmonary disease, diabetes, immunocompromised status), and vaccination history. You'll then need to recommend the appropriate vaccine(s) and schedule.
Test ACIP guidelines recall: Questions may ask about specific vaccine recommendations for certain age groups or risk factors, dosing schedules, or intervals between different vaccines.
Focus on contraindications and precautions: You might be asked to identify situations where a vaccine is contraindicated or requires precaution (e.g., severe allergic reaction, moderate-to-severe acute illness).
Evaluate pharmacist interventions: Scenarios could involve counseling a patient about vaccine side effects, addressing common misconceptions, or managing vaccine inventory.
Distinguish vaccine types: Understanding the difference between live attenuated, inactivated, recombinant, or adjuvanted vaccines and their implications for older or immunocompromised individuals.
Involve shared clinical decision-making: Questions may require you to identify situations where shared clinical decision-making is recommended (e.g., RSV, certain pneumococcal choices).

Example Scenario: A 72-year-old female with a history of COPD and type 2 diabetes presents to your pharmacy for her annual flu shot. She states she received a Pneumovax 23 (PPSV23) vaccine 3 years ago but is unsure about any other pneumococcal vaccines. She also mentions her grandchild recently had RSV. What immunization recommendations would you make today?
This type of question requires you to assess multiple vaccine needs, recall ACIP guidelines for pneumococcal revaccination and new RSV recommendations, and apply them to a specific patient profile.

Study Tips for Mastering Immunizations

To confidently tackle immunization questions on the CGP exam, consider these study strategies:

Master ACIP Adult Immunization Schedule: This is your primary resource. Focus specifically on the footnotes and special considerations for adults aged 65 and older, and those with underlying medical conditions.
Create Comparison Tables: For vaccines with multiple options (e.g., influenza, pneumococcal, RSV), create tables comparing their indications, formulations, dosing, and specific recommendations for older adults.
Understand the 'Why': Don't just memorize recommendations; understand the immunological basis (immunosenescence) and epidemiological reasons behind them. This helps with application to novel scenarios.
Practice Case Studies: Work through as many patient cases as possible. This is where you apply your knowledge to real-world situations, enhancing critical thinking. Many free practice questions and exam review courses offer these.
Review Contraindications and Precautions: Pay close attention to absolute and relative contraindications for each vaccine, especially in the context of common geriatric comorbidities.
Stay Updated: Immunization recommendations, especially for newer vaccines like RSV and COVID-19, evolve rapidly. Ensure your study materials reflect the most current ACIP guidelines as of April 2026.

Common Mistakes to Avoid

Be aware of these frequent pitfalls when studying and answering immunization questions:

Confusing Pneumococcal Schedules: Incorrectly sequencing PCV15/PCV20 and PPSV23, or misapplying previous vaccination history. Always consider the patient's full pneumococcal vaccine history.
Forgetting Annual Flu Shots: Assuming that because an older adult received a flu shot last year, they are set for the current year. Annual vaccination is critical.
Overlooking Tdap: Neglecting to recommend a one-time Tdap dose for adults who haven't received it, especially if they are around infants.
Misidentifying Contraindications: Confusing a mild illness with a contraindication, or failing to recognize a severe allergic reaction history as a true contraindication.
Ignoring Shared Clinical Decision-Making: Not recognizing when a discussion with the patient is required rather than a definitive recommendation (e.g., RSV, certain pneumococcal scenarios).
Not Considering Co-administration Rules: While many vaccines can be co-administered, some have specific spacing recommendations.

Quick Review / Summary

Immunizations are a cornerstone of preventive care in older adults, offering vital protection against severe, often life-threatening, infectious diseases. As a CGP Certified Geriatric Pharmacist, your expertise in this area is invaluable. Remember:

Immunosenescence makes older adults more vulnerable and influences vaccine efficacy.
Key vaccines include influenza (high-dose/adjuvanted), pneumococcal (PCV20 or PCV15/PPSV23), RZV (shingles), Tdap/Td, RSV, and COVID-19.
Always refer to the latest ACIP guidelines.
The pharmacist's role extends beyond administration to screening, education, counseling, and advocacy.
The CGP exam will test your ability to apply these concepts to complex patient scenarios.

By diligently studying these key areas and staying current with evolving recommendations, you will not only be well-prepared for the CGP exam but also significantly contribute to the health and well-being of the older adults you serve. For a more comprehensive overview of all exam topics, be sure to consult our Complete CGP Certified Geriatric Pharmacist Guide.